制度・支援
指定難病 — No.182

アペール症候群

検索語 Apert Syndrome ・ 最終更新 2026-09-17 14:30 ・ 最新に更新

Data Sheet
指定 No.182
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

観察研究
MK-01 · PMID 42676197

[Congenital structural respiratory disorders as the root cause of pediatric obstructive sleep apnea syndrome in Apert syndrome]

Abstract / 原文

This article examines the relationship between pediatric obstructive sleep apnea syndrome in Apert syndrome and congenital structural abnormalities of the respiratory system and skull. It reviews both invasive and non-invasive treatment methods for pediatric obstructive sleep apnea syndrome. The analysis includes various perspectives on the appropriate age for implementing invasive therapies in Apert syndrome.

Journal
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova(2026)
Authors
4名
Type
Journal Article, Review, English Abstract
PubMedで原文を見る
不明
MK-02 · PMID 42523095

Sphenopalatine Artery Pseudoaneurysm as a Rare Complication of Le Fort III Advancement in Apert Syndrome

Abstract / 原文

This report describes an especially rare postoperative pseudoaneurysm of the sphenopalatine artery following midface advancement using Le Fort III in an Apert syndrome patient. The Apert patient referenced in this report was a 13-year-old boy with severe midface hypoplasia, significant obstructive sleep apnea, and Angle Class III malocclusion. The patient underwent a low Le Fort III osteotomy, subsequently followed by gradual anterior distraction with an external halo distractor. One month postoperatively, the patient experienced recurrent, massive blood loss due to unilateral epistaxis. In order to immediately address life-threatening hemorrhaging and maintain advanced segment stability, the external distractors were removed, and a custom protraction face mask was applied for retention. A computerized tomography angiography showed a 4×3 mm saccular pseudoaneurysm from a branch of the left sphenopalatine artery in the pterygopalatine fossa near the posterior maxillary sinus wall. Careful microcatheterization and embolization achieved complete occlusion with preservation of adjacent collateral flow, resulting in immediate and sustained cessation of epistaxis, hemoglobin stabilization, and recovery without further complication. After 12 weeks of protraction face mask retention, achieved midface advancement remained stable; there was no recurrent bleeding over the next 6 months, and the patient's occlusion was classified as Angle Class II. This case underscores that recurrent severe postoperative epistaxis occurring after Le Fort III distraction requires immediate computerized tomography angiography to detect pseudoaneurysm and supports endovascular embolization as a safe, minimally invasive, highly effective first-line therapy within a multidisciplinary care model.

Journal
The Journal of craniofacial surgery(2026 Jul)
Authors
5名
Type
Journal Article
PubMedで原文を見る
観察研究
MK-03 · PMID 42505695

Apert Syndrome: Oral, Maxillofacial and Dental Management-A Narrative Clinical Review

Abstract / 原文

Apert syndrome is a rare genetic disorder characterized by premature fusion of the cranial sutures, syndactyly of the extremities, and distinct craniofacial deformities. The condition results from mutations in the FGFR2 gene, which disrupt normal craniofacial growth and lead to complex functional and morphological abnormalities. Patients with Apert syndrome commonly present with stomatognathic abnormalities, which significantly affect oral function and facial development. The management of Apert syndrome requires a multidisciplinary therapeutic approach. Surgical treatment strategies are typically staged according to the patient's age and clinical severity. Early interventions focus on cranial vault expansion procedures, such as fronto-orbital advancement and posterior vault distraction osteogenesis, aiming to relieve intracranial pressure and improve cranial morphology. During childhood and adolescence, midface advancement techniques are commonly performed to address midfacial hypoplasia and associated functional impairments. Early diagnosis and appropriate surgical planning play a crucial role in preventing complications and improving the functional, aesthetic, and psychosocial outcomes of patients with Apert syndrome. This narrative review summarizes current evidence while highlighting areas of ongoing controversy, particularly regarding surgical sequencing, orthodontic management and the integration of digital technologies into multidisciplinary care.

Journal
Clinics and practice(2026 Jul)
Authors
3名
Type
Journal Article, Review
PubMedで原文を見る
不明
MK-04 · PMID 42383896

Patient-Specific 3D Printed Palatal Protection Plates for Le Fort III Osteotomy in Syndromic Midface Hypoplasia: What We Do

Abstract / 原文

BackgroundSyndromic midface hypoplasia often includes a high or fragile palate that is vulnerable during midfacial disimpaction.SolutionWe created a patient-specific palatal protection plate produced through a fully digital workflow to stabilize and protect the palate.What we didAfter using conventional plates from 2022 to 2024, we implemented a digital design and printing workflow in 2025 and added suction-catheter sleeves to the Rowe forceps branches to improve retention.

Journal
The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association(2026 Jul)
Authors
7名
Type
Journal Article
PubMedで原文を見る
不明
MK-05 · PMID 42340830

Discussion: The APERT Severity Scale: A Quantitative Tool for Risk Stratification in Apert Syndrome

Journal
Plastic and reconstructive surgery(2026 Jul)
Authors
1名
Type
Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件を確認できます。

jRCT で検索日本の臨床研究実施計画 公開システム「対象疾患名」に アペール症候群 を入力し、「募集状況」で 募集中 にチェックして検索します。ClinicalTrials.gov で全件を見る世界最大の治験データベース(英語)「アペール症候群・日本・募集中」の条件で一覧が開きます。

※ jRCTは自動の大量データ取得を禁じているため、本サービスは自動収集せず、ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度アペール症候群の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。